Results 301 to 310 of about 1,223,864 (391)

Effect of dilazep on myocardial contractility following acute ischemia and reperfusion in isolated blood-perfused canine left ventricular muscle.

, 1981
Hiroshi Shida, Miyoharu Kobayashi, Shigetoshi Chiba   +2 more
openalex   +2 more sources

What is myocardial ischemia? [PDF]

Clinical Cardiology, 1991
openaire   +2 more sources

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury. [PDF]

Antioxidants (Basel)
Cucinotta L, Palermo N, Ardizzone A, Capra AP, Campolo M, Esposito E, Casili G, Lanza M.   +7 more
europepmc   +1 more source

Effects of calcium antagonists and free radical scavengers on myocardial ischemia and reperfusion injury: Evaluation by 31P-NMR spectroscopy.

, 1989
Fumitaka Ohsuzu, Shigeki Yanagida, Nobuhiro Sakata, H. Nakamura   +3 more
openalex   +2 more sources

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Multicellular 3D models to study myocardial ischemia-reperfusion injury. [PDF]

Front Cell Dev Biol
Peletier M, Zhang X, Klein S, Kroon J.
europepmc   +1 more source

Clinical significance and management of silent myocardial ischemia in patients with angina pectoris and myocardial infarction.

, 1989
Hiroshi Kishida, Takeshi Suzuki, Tsutomu Saito, Kaname Kiuchi, Hiroko Yasutake, KEIJI TANAKA, Noritake Hata, Nagaharu Fukuma   +7 more
openalex   +2 more sources

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source